title: Pharmacological profile of the tachykinin receptor involved in the stimulation of corticosteroid secretion in the frog Rana ridibunda.
abstract: It has recently been shown that the adrenal gland of the frog Rana ridibunda is densely innervated by a network of fibers containing two novel tachykinins, i.e. ranakinin (the counterpart of substance P) and [Leu3, Ile7]neurokinin A. Both ranakinin and [Leu3, Ile7]neurokinin A stimulate corticosteroid secretion from frog adrenal glands in vitro. In the present study, we have investigated the pharmacological profile of the receptors involved in the stimulatory action of ranakinin on perifused frog adrenal slices. The selective NK-1 receptor antagonists [D-Pro4, D-Trp7,9]substance P 4-11 and CP-96,345, did not affect the stimulatory action of ranakinin. The selective NK-1 agonist substance P 6-11 had no effect on corticosteroid secretion. The non-peptidic NK-1 receptor antagonist RP 67580 significantly reduced the stimulatory effect of ranakinin on corticosterone and aldosterone secretion by 57 and 55%, respectively. In addition, the dual NK-1/NK-2 receptor antagonist FK-224 significantly inhibited the effect of ranakinin on corticosterone (- 80%) and aldosterone secretion (- 95%). Finally, the amphiphilic analogue of substance P, [D-Pro2, D-Phe7, D-Trp9]substance P, had no effect on corticosteroid secretion. These data suggest that in the frog adrenal gland the stimulatory action of ranakinin on steroid secretion is mediated by a novel type of receptor which differs substantially from the mammalian NK-1 receptor subtype.
authors.affiliation: European Institute for Peptide Research (IFRMP no. 23), University of Rouen, Mont-Saint-Aignan, France.
authors.forename: M K
authors.initials: MK
authors.lastname: Kodjo
authors.forename: F
authors.initials: F
authors.lastname: Leboulenger
authors.forename: M
authors.initials: M
authors.lastname: Morra
authors.forename: J M
authors.initials: JM
authors.lastname: Conlon
authors.forename: H
authors.initials: H
authors.lastname: Vaudry
mesh_terms: D000305:Adrenal Cortex Hormones / Q000378:metabolism*; D000311:Adrenal Glands / Q000378:metabolism; D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D003345:Corticosterone / Q000378:metabolism; D007211:Indoles / Q000494:pharmacology; D054833:Isoindoles; D008297:Male; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D011898:Ranidae / Q000502:physiology*; D018039:Receptors, Tachykinin / Q000037:antagonists & inhibitors / Q000187:drug effects*
chemical_list: D000305:Adrenal Cortex Hormones; D007211:Indoles; D054833:Isoindoles; D009842:Oligopeptides; D010456:Peptides, Cyclic; D018039:Receptors, Tachykinin; C075570:FK 224; C071693:7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one; C071642:ranakinin; D000450:Aldosterone; D003345:Corticosterone